4//SEC Filing
Cabell Christopher 4
Accession 0001209191-20-037092
CIK 0001080709other
Filed
Jun 15, 8:00 PM ET
Accepted
Jun 16, 7:25 PM ET
Size
9.1 KB
Accession
0001209191-20-037092
Insider Transaction Report
Form 4
Cabell Christopher
EVP, Head of R&D, and CMO
Transactions
- Award
Employee Stock Option (right to buy)
2020-06-12+20,000→ 20,000 totalExercise: $61.31Exp: 2027-06-12→ Common Stock (20,000 underlying)
Footnotes (1)
- [F1]The options vest over four years, with 25% of the shares subject to the option vesting on June 12, 2021, and the remainder of the shares vesting monthly over the following three years in equal installments (except as otherwise necessary to avoid vesting of a fractional share), and are exercisable once vested.
Issuer
ARENA PHARMACEUTICALS INC
CIK 0001080709
Entity typeother
Related Parties
1- filerCIK 0001814928
Filing Metadata
- Form type
- 4
- Filed
- Jun 15, 8:00 PM ET
- Accepted
- Jun 16, 7:25 PM ET
- Size
- 9.1 KB